Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

CEVEC partners with Généthon to develop lentivirus packaging cell lines based on its CAP GT technology

CEVEC Pharmaceuticals GmbH, the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced a collaboration agreement with Généthon (Evry, France) for the development and exploitation of lentivirus packaging cell lines based on CEVEC’s proprietary CAP GT technology.

18 Sep 2015

Vomaris signs exclusive global commercial partnership with Metrex for Procellera Antimicrobial Wound Dressings

Vomaris Innovations, Inc. announced today that it has entered into an exclusive global commercial partnership for its microcurrent generating wound care products, Procellera Antimicrobial Wound Dressings, for the Long Term Care market with Metrex, a professional consumables brand within Kavo Kerr Group, which is a member of the Danaher Corporation.

15 Sep 2015

Surgeons use 3D printed implant in patient diagnosed with chest wall sarcoma

After being diagnosed with a chest wall sarcoma, a 54-year-old Spanish man's surgical team made the decision to remove his sternum and a portion of his rib cage and replace it with an implant.

14 Sep 2015

Researchers now have a way to study special proteins linked to different diseases, cancer

Researchers from Northwestern University and Yale University have developed a user-friendly technology to help scientists understand how proteins work and fix them when they are broken. Such knowledge could pave the way for new drugs for a myriad of diseases, including cancer.

11 Sep 2015

Biodegradable and bioresorbable polymers workshop hosted by Lucideon

Lucideon, the international materials technology company, in conjunction with the University of Cambridge, Granta Design, NC State University and the University of North Carolina, is hosting a 2-day ‘Science for Industry’ workshop on Biodegradable and Bioresorbable Polymers (BBPs).

From Lucideon 10 Sep 2015

Dr Tavormina wins IDT award for global warming and methane sinks research

Integrated DNA Technologies (IDT), the world leader in custom oligonucleotide synthesis, awarded the inaugural IDT ISO 14001 Sustainability Award to Dr Patricia Tavormina of the Division of Geological and Planetary Sciences at the California Institute of Technology. Dr Tavormina's research focuses on naturally occurring methane-oxidizing bacteria (MOB), and the role they play in limiting greenhouse gases, which contribute to global warming.

From Integrated DNA Technologies 10 Sep 2015

Impax Laboratories receives FDA notice regarding Hayward manufacturing facility

Impax Laboratories, Inc. today announced that it received written notice from the United States Food and Drug Administration verifying that the Company has successfully addressed all items raised by the FDA in the May 2011 Warning Letter relating to its Hayward, California manufacturing facility.

8 Sep 2015

CEVEC launches unique cell-expression system for scalable production of gene therapy vectors

CEVEC Pharmaceuticals GmbH, the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced the introduction of its unique cell-expression system, CAP GT, for the fully scalable production of gene therapy vectors, based on the Company's proprietary CAP technology.

8 Sep 2015

IDT to host webinar on high throughput qPCR profiling studies

Integrated DNA Technologies will be hosting a webinar to help researchers get the most out of gene expression studies that analyze large numbers of samples.

From Integrated DNA Technologies 4 Sep 2015

Cipla enters into definitive agreements to acquire two US-based companies

Cipla, a global pharmaceutical company which uses technology and innovation to meet the everyday needs of all patients, today announced that its UK arm, Cipla EU has entered into definitive agreements to acquire two US-based companies, InvaGen Pharmaceuticals Inc., and Exelan Pharmaceuticals Inc.

4 Sep 2015

Inhalation exposure to PM2.5 pollution triggers liver fibrosis

A research team led by Kezhong Zhang, Ph.D., at the Wayne State University School of Medicine's Center for Molecular Medicine and Genetics, has discovered that exposure to air pollution has a direct adverse health effect on the liver and causes liver fibrosis, an illness associated with metabolic disease and liver cancer.

3 Sep 2015

Acal BFi inks channel partner agreement in Europe with SynQor

Acal BFi, European leader in advanced technology solutions, have signed a channel partner agreement in Europe with SynQor to include UK, Ireland, Denmark, Sweden, Norway, Finland, Belgium, Netherlands, Luxemburg and Italy.

3 Sep 2015

Lannett enters into definitive agreement to purchase KU for $1.23 billion

Lannett Company, Inc. today announced that it has signed a definitive agreement to purchase Kremers Urban Pharmaceuticals Inc., the U.S. specialty generic pharmaceuticals subsidiary of global biopharmaceuticals company UCB S.A., for $1.23 billion, plus potential contingency payments.

3 Sep 2015

Ascletis completes US$35 million (RMB 220 million) financing

Ascletis announced today the completion of a US$35 million (RMB 220 million) financing. The investment was led by C-Bridge Capital, joined by Tasly Pharmaceutical and Singapore-based Pavilion Capital. The valuation of the Company before financing was US$300 million.

2 Sep 2015

Morgan Advanced Materials to launch standard brazed ceramic filament supports for analytical market

Morgan Advanced Materials has announced plans to launch its own range of standard brazed filament supports, complementing its existing portfolio of high-specification products.

2 Sep 2015

HeartWare International signs definitive agreement to acquire Valtech

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, announced today that it has entered into a definitive agreement to acquire Valtech Cardio, Ltd.

2 Sep 2015

Laccure Pessary developed for treatment and prevention of bacterial vaginosis now ready for commercialisation

The Swedish company Laccure AB has developed a breakthrough women's health product that is effective, safe and user-friendly. Laccure's owners are now aiming to divest the company to a buyer with appropriate resources to launch the product.

1 Sep 2015

AMRI, Saneca Pharmaceuticals collaborate to develop and market opium-derived APIs

AMRI and Saneca Pharmaceuticals, a.s. today announced a strategic collaboration focused on the development, manufacture and marketing of a portfolio of opium-derived active pharmaceutical ingredients, ("APIs").

31 Aug 2015

Can-Fite BioPharma announces Q2 financial results for 2015, updates drug development programs

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the six months ended June 30, 2015 and updates on its drug development programs.

28 Aug 2015

New device turns paralysis victims' breath into words

A new device which transforms paralysis victims' breath into words - believed to be the first invention of its kind - has been developed by academics from Loughborough University.

28 Aug 2015

Manufacturing News and Research

Further Reading

CEVEC partners with Généthon to develop lentivirus packaging cell lines based on its CAP GT technology

Vomaris signs exclusive global commercial partnership with Metrex for Procellera Antimicrobial Wound Dressings

Surgeons use 3D printed implant in patient diagnosed with chest wall sarcoma

Researchers now have a way to study special proteins linked to different diseases, cancer

Biodegradable and bioresorbable polymers workshop hosted by Lucideon

Dr Tavormina wins IDT award for global warming and methane sinks research

Impax Laboratories receives FDA notice regarding Hayward manufacturing facility

CEVEC launches unique cell-expression system for scalable production of gene therapy vectors

IDT to host webinar on high throughput qPCR profiling studies

Cipla enters into definitive agreements to acquire two US-based companies

Inhalation exposure to PM2.5 pollution triggers liver fibrosis

Acal BFi inks channel partner agreement in Europe with SynQor

Lannett enters into definitive agreement to purchase KU for $1.23 billion

Ascletis completes US$35 million (RMB 220 million) financing

Morgan Advanced Materials to launch standard brazed ceramic filament supports for analytical market

HeartWare International signs definitive agreement to acquire Valtech

Laccure Pessary developed for treatment and prevention of bacterial vaginosis now ready for commercialisation

AMRI, Saneca Pharmaceuticals collaborate to develop and market opium-derived APIs

Can-Fite BioPharma announces Q2 financial results for 2015, updates drug development programs

New device turns paralysis victims' breath into words

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest Life Science News